英文名稱 | Valbenazine Tosylate; Valbenazine Ditosylate; NBI-98854 Tosylate |
---|---|
中文名稱 | 纈苯那嗪甲苯磺酸鹽; 纈苯那嗪二甲苯磺酸鹽 |
CAS號 | 1639208-54-0 |
分子式 | C38H54N2O10S2 |
分子量 | 762.97 |
儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
英文名稱 | Valbenazine Tosylate; Valbenazine Ditosylate; NBI-98854 Tosylate |
---|---|
中文名稱 | 纈苯那嗪甲苯磺酸鹽; 纈苯那嗪二甲苯磺酸鹽 |
CAS號 | 1639208-54-0 |
分子式 | C38H54N2O10S2 |
分子量 | 762.97 |
儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Valbenazine tosylate (NBI-98854; NBI98854; MT5199; MT-5199; Ingrezza), the tosylate salt of valbenazine, is a VMAT2 (vesicular monoamine transporter 2) inhibitor approved in 2017 by FDA for the treatment of TD/tardive dyskinesia (uncontrollable movement of the face, tongue, or other body parts).